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On the basis of previous studies that showed a nega-
tive association between HLA-A11 and skin cancer in 
renal transplant recipients and a positive association 
with HLA-B27 and HLA-DR7, we performed a study 
in Queensland with 1098 recipients to address the 
question of whether the same associations could be 
found. The influence of HLA mismatching and HLA 
homozygosity on the risk of skin cancer was also 
studied. In contrast to earlier studies, HLA-A11 was 
associated with an increased risk of skin cancer. On 
the other hand, we confirmed that the HLA-B27 
antigen was associated with the development of skin 
cancer, but only when the development of basal cell 
carcinomas alone was considered, and we confirmed 
that there is a weak but not statistically significant 
association with HLA-DR7. No association between 
HLA mismatching or HLA homozygosity and the 
R e,nal transplant recipients are at an increased risk for the development of skin cancer, most frequently squamous cell carcinomas, followed by basal cell carcinomas (Hardie el ai, 1980; Boyle e/ ai, 1984; Hartevelt el ai, 1990; Bouwes Bavinck el ai, 1991 b; 
Bouwes Bavinck and Vermeer, 1995; Bouwes Bavinck el ai, 1996). 
Skin cancer is parti cularly a problem in Queensland, AustraHa, 
where people have excessive exposure to sunlight (Hardie el ai , 
1980; Bouwes Bavinck e/ ai, 1996) , but can also be a serious 
problem in countries at higher latitudes with only a moderate 
amount of exposure to sunli ght, such as the Netherlands (Hartevelt 
el ai, 1990; Bouwes Bavinck and Verm eer, 1.995) . Immunosuppres-
sive therapy, solar radiation , and vira l warts (infection with human 
papilloma viruses) are believed to be the most important risk factors 
for the development of skin cancers in renal transplant recipients 
(Boyle cl ai, 1984; Barr el ai, 1989; Bouwes Bavinck el ai, 1993 ; de 
Jong-Tieben el ai, 1995; Tieben cl ai, 1994; Berkhout el ai, 1995), 
although genetic factors, and in particular the human leukocyte 
antigen (HLA) system , are also involved in the development of skin 
cancer (Bouwes Bavin ck et ai, 1990, 1991 a, 1991 b; Czarnecki el ai , 
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development of skin cancer was observed. Environ-
mental factors such as different levels of exposure to 
sunlight and infection with human papillomaviruses 
are factors that are most likely to be involved. We 
hypothesize that human papiIlomavirus-induced an-
tigens prevail in the skin cancers in the recipients 
living in the Netherlands, whereas antigens induced 
by solar radiation, the so-called "photo-antigens," 
may be more common in the skin cancers of the 
recipients living in Queensland. Exposure to sunlight 
can also induce immunologic unresponsiveness, and 
excessive exposure to sunlight in Australia may, 
therefore, simply override the risk factors that are 
important in countries with a more temperate cli-
mate. Key lVol'ds: tlllltOI' illummitylmajol' Ilistocolllpatibility 
complexllllll1lall papilloma.l1il'lls. ] lIwest Deyltlatol 108: 
708-711, 1997 
1992a, 1992b; Bouwes Bavinck et ai, 1993; Bouwes Bavinck and 
C laas, 1994; Bouwes Bavinck el ai, 1994). 
In the Dutch renal transplant population that we studied previ-
ously, we found a significant negative association between HLA-Al l 
and skin cancer (Bouwes Bavinck et ai, 1991a) (Table I). The same 
trend was found in tlle United Kingdom (McGregor el ai, 1992; Glover 
e/ ai, 1993) and in Melboume, Australia (Czamecki e/ III, 1992a) 
(Table I). By contrast, no protective effect of HLA-A 11 against skin 
cancer was observed in Sweden. Blolunc and Sandberg (personal 
conununication) studied 74 renal transplant recipients with skin can-
cer. Nine (12.2%) had the HLA-Al1 antigen, whereas dle fiequency 
ofHLA-A11 in the general population in Sweden is 8.8'1'0 (Table 1). 
Odler associations of HLA antigens with skin cancer are presented in 
Table II. 
On the basis of previous studies that showed a negative associ-
ation between HLA-Al1 and skin cancer in renal transplant 
recipients and a positive association with HLA-B27 and HLA- DR7. 
we performed a study with 1098 recipients to address the question 
whether the same associations cou ld be found in renal transplant 
recipients living in the (sub)tropical climate of Queensland, Aus-
tralia. The influence of HLA mismatching and HLA homozygosity 
on the ri sk of skin cancer was also studicd. 
PATIENTS AND METHODS 
All patients receiving renal transplants at Prin cess Alexandra Hos-
pital, Brisbane, Australia, between September 1969 and March 31. 
1994, were studied (Bouwes Bavinck e/ ai, 1996) . Princess Alexan-
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Table I. Association of HLA-All with Skin Cancer in Renal Transplant Recipients 
Patients with 
Skin Cancer Controls 
Location of 
Study + + 
The Netherlands 0 66 6 1 444 
South Austra lia 2 28 22 179 
United Kingdom 2 27 34 258 
5 41 7 39 
Sweden 9 65 8.8% 
Queensland, Austra lia 46 225 91 736 
I I Calcul ated with WooH:"'Haldanc .mal ysis (sec tex t). 
" RR, relative risk: C I. confidence interval; np. not possible . 
dra Hospita l is the on ly hospita l w here renal transplantation is 
performed in the state of Queensland, which has a popula tion of3.3 
million. Demographic information on the Queensland patients was 
extracted from the Austra liall and N ew Zealand D ialysis and 
Transplant Registry data base. Patients undergoing transplantation 
in Brisbane had been referred alm ost exclusively fi'om dialysis units 
in hospitals th rougho ut Q ueensland . Dctailed skin cancer data were 
obtained £i'om cancer survey sheets of the D ialysis and Transplant 
Registry, iJlcluding the datc of first diagnosis of skin cancer and by 
separating squamous cell carcinoma and basal cell carcinoma. All 
skin cancers were confirmed histologica lly. 
Typing for I-lLA-A, -B, and -DR antigens was perfonn ed wi th 
se ts of well-defined alloan tisera by the standard complement-
dependent lymphocytotoxicity test for HLA-A and -B specitied by 
the National Lnstitutes of Health (Ray cl 111,1979) and the two- color 
fluoresce nce technique for HLA-DR typing (van Rood el 111,1976). 
Matching did not account for antigen spli ts. T he degree of mis-
matching was assessed by countin g the antigens p resent in the 
donor but absent in the recipient. If a patient had received two 
transplants (155 patients) or three (18 patients), only the first 
transplan t was considered in the assessment of the mismatching in 
a sin,ilar way as in an earlier study with renal transp lant recipients 
in the N etherl ands (Bouwes Bavin ck ('I Il l, 1991 b). 
W h en onl y one antigen could be iden tified fo r a given locus, th e 
recipient o r the donor was considered to be homozygous for that 
locus, although true homozygosity can be confirmed only by fa lTlily 
studies (Bouwes Baviuck el Il l, 1991 b). HLA typing of the patients' 
parents was not performed . 
Dilferen ces in the frequ ency ofHLA antigens in difFe rent subsets 
were calcula ted by Woolf-Haldane ana lysis (Haldane, 1955; 
Table II. Associations Reported between HLA Antige ns 








for HLA D I~ 
Association 
Increased risk of skin cancer 
Increased l;sk of skin cancer 
No npparc ll t class switch 
fi'o l11 IgM to IgG with re-
ga rd to aJltibodics directed 
against the fusion protein 
,B-galactosidasc and the 
late antigen L1 of hUlllan 
pap illol11a virus type 8 
Increascd risk of skin cancer 
No increased risk of skin 
cancer 
Increased t;sk of skin cancer 
Refcrcnce(s) 
Bouwes Bavinck el III 
(1990) ; Czamccki 
el a1 (19923) 
BOllwcs Bavinck et (I f 
(1992); Czamecki 
cl iii (1 992a) 
BOll wcs Bavinck c( (1/ 
(1 993) 
UOllwes Bavillck Cf al 
(1991b) 
Roegcr cl a1 (1992) 
Bouwes Bavinck cl a1 
(1991b) 
Ca.lc ulati on s·' 
1U1..
" 
95% CI" p Valuc Reference 
0.05 0.007; 0.40 0.004 Bouwcs Bavinck el a1 (1990) 
0.70 0.2; 2.5 0.58 Cza rnecki ('I a1 (1992a) 
0.68 0.2; 2.4 0.54 McG regor cl a1 (1992) 
0.70 0.2; 2.2 0.54 Glovcr el a1 (1993) 
- 1.2 np" np Blohmc (personal communication) 
1.7 1 .1; 2.4 0.009 Current study 
Woolf, 1955), and homozygosity and th e degree ofHLA matching 
between the patients w ith and without skin can cer was calculated 
by ,..(' ana lysis. Since HLA-Al1, -B27, an d -DR7 were tested a 
priori, correction for the number of antigens tested is not necessary. 
In addition, univariate and mul tivariate analyses were perfOn1led 
w ith th e Cox proportional haza rds model. T he number of persoll 
years in the latter analyses was calculated from the date of the first 
transplant to the date of diagnosis of the first skin can cer , the date 
of rejection of th e last transp lant, the patient's death. or the end of 
the study period on March 31, 1994. T he time periods b e tween 
rejections and subsequent transp lan tations were n ot counted. The 
age of th e patients at first tran spl antation (years) was introduced as 
a continuous variable, and tbe sex (male/ female) was a dichoto-
mous variable. The analyses with the Cox proportional hazards 
m odel were performed with the statistical software package 
EGRET (Statistics and Epidemiology R esearch Corporation, Seat-
tie . WA) and the oth er statistical analyses were performed w ith the 
SAS (SAS Institute , Cary, NC) statistica l software package. 
RESULTS 
In Brisbane, in the period from September 1969 until March 31, 
1994, a tota l of 1482 tra nsp lantations were performed in 1273 
p atients (Bouwes Bavinck pI nl, 1996). A total of96 non-Caucasoid 
pati ents were excl uded £i'om the analyses. In addition, we excluded 
six patients who received their first transplantation elsewhere, 13 
patients w ho rejected the graft within 24 h after the u·ansplamation. 
46 patients w ho had already skin can cer before th e transp lantation. 
and 14 patients who deve loped the fi rst skin cancer after the 
rejection of the l ast graft, leaving a group of 1098 patients to be 
further an alyzed . .A total of 2751 skin cancers were diagnosed in 
271 patients (25%) of w hom 83 developed only squamous cell 
carcinomas. 13 6 developed both squamous cell carcin omas and 
basal ce ll carcinomas, and 52 develo ped only basal cell carcinomas 
(Bouwes Bavinck el ai, 1996). Skin type was not recorded. 
Data on HLA class I antigens were ava ilable for all 1098 assessed 
recipients and for all but three donors . Data 011 HLA class Il 
an tigens were lackin g for 240 rec ipients and 296 donors , mainly 
because transplan tation had been performed before typ ing for class 
II antigens was introduced. 
In contrast to the earije r publications, we did not o bserve a 
protective efFect of HLA-A 11 , but instead. in the Queensland 
population this HLA antigen was associated with an increased risk 
of skin cancer (Tables I, III). T he crude hazard ratio of developin g 
skin cancer in the presen ce of tile HLA-A 11 antigen was 1.6 (95
'
)1(, 
confiden ce interval: 1.2 to 2.2), and tile hazard ratio adjusted for 
the sex and age of the patients was 1.7 (95% confiden ce interva l: 
1.3 to 2.4). T he crude and adjusted hazard ratios with 95% 
confidence interval were 1.7 (J.2 to 2.4) and 1.9 (1.3 to 2.7) for the 
developmen t of squamous cell carcino ma and 1.5 (1.0 to 2.3) and 
1.6 (1.1 to 2.4) for the developm ent of basa l cetl carcinoma , 
respective ly. 
The HLA-B27 antigen was also associated with the development 
of skin can cer in th e Q ueensland population, but only w hen the 
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Table III. Frequency of Relevant Antigens in Renal Transplant Recipients with and without Skin Cancer" 
T o tal pa ticllts tcsted 
All + padcllts 
U27 ; patic llts 
To tal pa tic llts l'cs tcd 
D Il? ' patients 
All Skin ea ll ccr 
271 
46(17.0)' 
14 (5 .2) 
197 
50 (25.4) 
O nl y sec" 
83 




{I Values lire lIumbers of p'Hicllts .1Ild [he I III 111 ucr:; in paren th eses arc percentages. 
I. sec. squamous cell carcinoma ; uee. basa l ce ll C:1rCillolna . 
, p :S (l.OS. 
development of basal ce ll carcinomas alone was considered (Table 
Ill). 
The fi'equency of the HLA-DR.7 antigen tended to be higher in 
the patients with skin ca ncer , but statistica l signifi cance was not 
reached (Table III). T he crude hna rd ratio of developing skin 
ca ncer ill the presence of the HLA-DR7 antigen was 1.3 (95 % 
confiden ce interval: 0 .97 to :1.8) , and the hazard ratio adjusted for 
the sex and age of the patients was '1.3 (95% confidence interval: 
0.94 to 1.8). T he crude and adjusted hazard ratios with 95'X, 
confidence interval were 1.3 (0.90 to 1.9) and 1.3 (0.88 to 1.8) for 
the developmen t of squamous cell carcin oma and 1.2 (0 .79 to 1.8) 
and 1.1 (0.76 to 1.7) for the developmen t of basa l cell carcinom a, 
respectively. 
No significa nt associations were found between any other HLA 
antigens and skin c;mcer. 
Homozygosity for class J and class" an tigens and mismatching 
for these antigens were not associated with the development of skin 
can cer in the Queensland popuhtion. Specifically. no association of 
mismatchin g for the HLA-B antigens with the development of 
squamo us ce lJ carcinom a was observed. 
DlSCUSSION 
Rega rding the association between HLA-A 1:1 and the development 
of skin cancer, this study shows is a striking reversa l between the 
renal transplant recipients li ving in Queensland , Australia, and 
those li ving in the Netherl ands (Bouwes Bavi nck cI nl, 1991a): in 
Q ueensland, HLA-A 11 is associated w ith a signiflc;l11tl y increased 
l;sk of skin c,l11cer, and by contrast, ill the Netherlands none of the 
66 recipients with ski n can cer had the H LA-A 11 antigen (Bouwes 
Bavinck ct ai , 1991 a). On the other hand , this study confIrms to 
some extent the results of earlier studies (Bouwes Bavinck el nl. 
1991 a; Czarnecki et nl , 1992a) indicating that the presence of 
HLA-B27 and HLA-DJI...7 antigens is associated with an in creased 
susceptibility to sk.in cancer in renal transplant recipients. 
A possib le explanatio n for the apparent confli cting associations 
between HLA-All and the development of ski n cancer in Queens-
land and the Netherlands may be a different genetic backgro und of 
the populations. T he genetic ba ckground. however, as character-
ized by the fi-equency of HLA antigens, does not dilfer much 
between the two co untries . It is more likely that differences in 
environmental factors, such as exposure to sunlight and infection 
with human papillomaviruses, are facto rs determin in g the differ-
ences between the two populatiOJ]S. 111 the D utch renal transplant 
recipients DNA of epidermodysplas ia verruciformis associated hu-
man papilloma viruses (HPV-15. -19 , -20, - 23, -25, and -38 and six 
potentially novel types) was fou nd in more th;lI1 80'1., of th e skin 
cancers (Berkhout CI ai , 1995; de Jong-Tieben eI ai, 1995) . It is 
conceivable that in the Dutch cohort, antigens induced by human 
papillom:lviruses may be present in the skin ca ncers and this may 
playa ro le in the immune response against skin cancer. 
Excessive exposure to sunlight in Queensland is th e most obv ious 
dilference from the situ ation in the Netherlands. Ultraviolet-
irradiation-induced DNA changes can lead to the production of 
immunogenic proteins, or "photo- antigens ." In this way, exposure 
to su nlight can influcnce the typc of antigen s present in the skin 
cancers . Su nlight can also influence the immun e reactions involved. 
Ultraviolct-irradiation-induced DNA damage C;111 trigger a cascade 
sec alld Bee" 
136 
23 (16.9)'" 
4 (2 .9) 
93 
22 (23.7) 
O nl y Bee 
52 
8 (J 5.4) 
8 ( 15.4)' 
39 
10(25.6) 






of events leading ultimately to a state of antigen-specific systemic 
T - lymphocyte-mediated immunosuppress ion (Kripke , 1984, 1994). 
It is conceivable that photo-antigens are f.'1 r more common in the 
skin cancers of transplant recipients living in Queensland . By 
contrast, in the Dutch cohort, difFerent antigens, possibly induced 
by human papiUomaviruses, m ay prevail. 
Finall y. the excessive exposure to su nli ght in Queensland may 
simpl y override the effect of other l'i sk facto rs that are important in 
co untries with a mor'e temperate climate. T he absence of an effect 
of mismatching for the HLA-B antigens on the developm ent of 
sq uamous cell ca rcinoma in the Queensland population and the 
absence of an association of homozygosity for the HLA class n 
anti gens with skin cancer co uld also be explaiJ1 ed by tlus mecha-
niSll1. 
We (1/(lIIk Il,e A llslmlill alld Nell' Zcalal/d Dialysis al/d Tml/splal/ / R egis,,}' I"r 
permitti"g access to ,lIci,. dmn. The A llstmlia ami Ne", ZCll lal1d Dial}'sis mId 
T ral/sjll(1II1 R~~ is lrl' is sllpjJorlcd {'l' ,he A I/slmlial/ Kidl/C)' FOII/lllalioll. The rcsenrcl, 
"I'DI'. BO'II"CS BflI/ jllck "as beell /IIade possible "J' a fe/lo'I'sltip '~F Ihe Royol 
Nelh,.rlal/cls Awdell/)' '?{ Arls flI,d SciCllccs. /IVe Ihnllk Dr. Joe d'AlI/ am lor helpfid 
disf llSS;OIl with regard tel the nlur/)'sis of fhe rifll (l. 
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